recombinant alpha-1 antitrypsin (GeneCopoeia)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerecombinant alpha-1 antitrypsin (GeneCopoeia)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAlpha-1-antiproteinase modulatorsTrypsin inhibitors
TargetsAlpha-1-antiproteinaseTrypsin
Therapy Area/IndicationsEmphysema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGeneCopoeia Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGeneCopoeia Inc
Active IndicationsN/A
Inactive IndicationsEmphysema

Other Information

ATC CodeN/A
Related LinksN/A